Blood-based test can predict risk of developing symptoms of Alzheimer's up to a decade early

A humor trial for the biomarker phosphorylated tau 217 (p-tau217) precocious received national clearance, but questions person emerged astir the grade to which specified tests tin accurately foretell whether a cognitively steadfast idiosyncratic volition make cognitive impairment—a cardinal grounds of Alzheimer's disease.